Clostridioides difficile cell wall peptidoglycan

Clostridioides difficile cell wall peptidoglycan is a fundamental structural polymer essential for the survival and integrity of the C. difficile bacterium. It consists of alternating residues of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc), cross-linked by short peptide chains, which provide the mechanical strength necessary to withstand internal osmotic pressure (Peltier et al., 2011, J. Biol. Chem.). In the context of infection, this layer is vital for the vegetative growth of the pathogen within the human colon, where it releases toxins that cause severe inflammation and diarrhea (CDC, 2022). Because peptidoglycan is unique to bacteria and absent in humans, it serves as a primary target for several classes of antibiotics. Glycopeptide antibiotics, such as vancomycin, exert their bactericidal effect by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors, thereby sterically hindering the assembly of the cell wall (Bouttier et al., 2019, Front. Microbiol.). Disrupting this structure leads to bacterial lysis and is a cornerstone of treating Clostridioides difficile infections (CDI).

Other names

C. difficile peptidoglycanMureinBacterial cell wall peptidoglycanC. diff cell wall

Inhibition of cell wall synthesis by binding to peptidoglycan precursors (e.g., D-Ala-D-Ala) or inhibiting transglycosylation and transpeptidation enzymes.